60 results on '"p16INK4a"'
Search Results
2. The in situ local immune response, tumour senescence and proliferation in colorectal cancer
3. Interplay between Homeobox proteins and Polycomb repressive complexes in p16INK4a regulation
4. Inverse association of p16INK4a and p14ARF methylation of the CDKN2a locus in different Gleason scores of prostate cancer
5. p16Ink4a overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors
6. Cyclin-dependent kinase 1 expression is inhibited by p16INK4a at the post-transcriptional level through the microRNA pathway
7. Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15INK4B tumor suppressor gene
8. Transcriptional factor HBP1 targets P16INK4A, upregulating its expression and consequently is involved in Ras-induced premature senescence
9. The tumor suppressor p16Ink4a regulates T lymphocyte survival
10. p16Ink4a or p19Arf loss contributes to Tal1-induced leukemogenesis in mice
11. Site-specific DNA methylation by a complex of PU.1 and Dnmt3a/b
12. A mutation hotspot at the p14ARF splice site
13. Infectious delivery of the 132 kb CDKN2A/CDKN2B genomic DNA region results in correctly spliced gene expression and growth suppression in glioma cells
14. Alterations in the p16INK4a and p53 tumor suppressor genes of hTERT-immortalized human fibroblasts
15. The tumor suppressor p16INK4a gene is a regulator of apoptosis induced by ultraviolet light and cisplatin
16. Human melanocyte senescence and melanoma susceptibility genes
17. ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a
18. Methylation, expression, and mutation analysis of the cell cycle control genes in human brain tumors
19. Raf-1-induced growth arrest in human mammary epithelial cells is p16-independent and is overcome in immortal cells during conversion
20. A strong candidate gene for the Papg1 locus on mouse chromosome 4 affecting lung tumor progression
21. Re-expression of hSNF5/INI1/BAF47 in pediatric tumor cells leads to G1arrest associated with induction of p16ink4a and activation of RB
22. Patterns of gene promoter methylation in squamous cell cancer of the head and neck
23. P16INK4A is implicated in both the immediate and adaptative response of human keratinocytes to UVB irradiation
24. Coincident inactivation of 14-3-3σ and p16INK4a is an early event in vulval squamous neoplasia
25. p16INK4a loss and sensitivity in KSHV associated primary effusion lymphoma
26. Id proteins in cell cycle control and cellular senescence
27. Increased expression of unmethylated CDKN2D by 5-aza-2′-deoxycytidine in human lung cancer cells
28. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas
29. Loss of p16 pathways stabilizes EWS/FLI1 expression and complements EWS/FLI1 mediated transformation
30. Expression of p15 and p15.5 products in neuroendocrine lung tumours: relationship with p15INK4b methylation status
31. A melanoma-associated germline mutation in exon 1β inactivates p14ARF
32. Acquired expression of transcriptionally active p73 in hepatocellular carcinoma cells
33. Prognostic significance of p16INK4a immunocytochemistry in adult ALL with standard risk karyotype
34. Quantitative real-time PCR does not show selective targeting of p14ARF but concomitant inactivation of both p16INK4A and p14ARF in 105 human primary gliomas
35. Adenovirus-mediated transfer of p53 and p16INK4a results in pancreatic cancer regression in vitro and in vivo
36. Hypermethylation of p16INK4A gene promoter during the progression of plasma cell dyscrasia
37. JunB suppresses cell proliferation by transcriptional activation of p16INK4a expression
38. LMP1 of Epstein–Barr virus suppresses cellular senescence associated with the inhibition of p16INK4a expression
39. p16INK4a can initiate an autonomous senescence program
40. High incidence of allelic loss on chromosome 5 and inactivation of p15INK4B and p16INK4A tumor suppressor genes in oxystress-induced renal cell carcinoma of rats
41. Enhanced expression of p16ink4a is associated with a poor prognosis in childhood acute lymphoblastic leukemia
42. Homozygous deletions of methylthioadenosine phosphorylase (MTAP) are more frequent than p16INK4A (CDKN2) homozygous deletions in primary non-small cell lung cancers (NSCLC)
43. Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation
44. Re-expression of p16INK4a in mesothelioma cells results in cell cycle arrest, cell death, tumor suppression and tumor regression
45. Hypomethylation and increased gene expression of p16INK4a in primary and metastatic breast carcinoma as compared to normal breast tissue
46. Agents that cause DNA double strand breaks lead to p16INK4a enrichment and the premature senescence of normal fibroblasts
47. Characterization of the cyclin-dependent kinase inhibitory domain of the INK4 family as a model for a synthetic tumour suppressor molecule
48. Mechanisms of p16INK4A inactivation in non small-cell lung cancers
49. Methylation of the multi tumor suppressor gene-2 (MTS2, CDKN1, p15INK4B) in childhood acute lymphoblastic leukemia
50. The human protein p19ARF is not detected in hemopoietic human cell lines that abundantly express the alternative β transcript of the p16INK4a/MTS1 gene
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.